Laryngeal sarcoidosis: treatment with the antileprosy drug clofazimine.

Abstract

Sarcoidosis is a chronic systemic granulomatous disease that occasionally affects the larynx. When the larynx is affected, the symptoms are frequently mild, but severe airway obstruction can occur. Although systemic corticosteroids are helpful, patients may become refractory to further drug administration. The current methods of treatment are here summarized, and the patient literature is reviewed. We also report a case of a young patient suffering from laryngeal sarcoidosis successfully treated by the antileprosy agent clofazimine and propose it as an alternative treatment of laryngeal sarcoidosis in patients refractory to corticosteroids.

Cite this paper

@article{Ridder2000LaryngealST, title={Laryngeal sarcoidosis: treatment with the antileprosy drug clofazimine.}, author={Gerd J{\"{u}rgen Ridder and H Strohh{\"a}cker and Erwin L{\"{o}hle and Avishay Golz and Milo Fradis}, journal={The Annals of otology, rhinology, and laryngology}, year={2000}, volume={109 12 Pt 1}, pages={1146-9} }